Treating Lung Cancer in COVID-19 Times: Update From ESMO Treating Lung Cancer in COVID-19 Times: Update From ESMO

Lung cancer experts issued thoughtful recommendations on how to approach lung cancer during the pandemic while still limiting exposure to COVID-19 as patients are in hospital receiving treatment.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Related Links:

Google and Apple Launch Highly Anticipated Contact Tracing Technology The two tech rivals have developed the Exposure Notification technology which can inform someone if they may have come in contact with a person that was diagnosed with COVID-19. The move comes as more tech companies are stepping up to help in the fight against the pandemic. The Exposure Notification has the specific goal of rapid notification, which is especially important to slow the spread of the disease with a virus that can be spread asymptomatically. NFL Explores Modified Face Masks for Player Helmets The medical director for the NFL Players Associa...
Source: MDDI - Category: Medical Devices Authors: Tags: COVID-19 Digital Health Source Type: news
Johnson &Johnson announced Tuesday that it will stop selling its iconic, talc-based baby powder, the target of thousands of lawsuits claiming that its talc was contaminated with asbestos, which led to cancers such as mesothelioma and ovarian cancer. The company said the stoppage is only in the United States and Canada, citing a decline in consumer demand and “misinformation” about the safety of the product. “Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product ...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Half of apartment dwellers in Los Angeles report having been exposed to unwanted secondhand smoke in their homes in the last year, and 9 in 10 of them say they favor policies banning smoking from their buildings, a  new study by researchers at the UCLA Center for Health Policy Research reveals.Owners of multiunit housing properties in Los Angeles also expressed strong support, with 92% saying they favor smoke-free policies, according to the study, which surveyed more than 5,000 tenants and owners in some of the city ’s most densely populated areas.“We found that 1 in 2 tenants said that they were...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
When it comes to health concerns, the COVID-19 pandemic is top of mind for most people right now. And that’s for good reason. But there is some very good non-COVID health news that may not be getting the attention it deserves. According to the CDC, the rates of six of the top 10 causes of death in this country, which account for about three-quarters of all deaths, have been declining. That’s remarkable. And these improvements are occurring despite an aging population and an obesity epidemic that affects several health conditions. Six positive health trends Let’s look at the trends in these conditions...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Cancer Health Health trends Heart Health Source Type: blogs
(International Association for the Study of Lung Cancer) To help oncologists address the many challenges COVID-19-positive lung cancer patients present, a team of global lung cancer specialists this week published a review of lung cancer treatments for patients with COVID-19 in the current issue of the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Abstract INTRODUCTION: A pandemic coronavirus, SARS-CoV-2, causes COVID-19, a potentially life-threatening respiratory disease. Patients with cancer may have compromised immunity due to their malignancy and/or treatment, and may be at elevated risk of severe COVID-19. Community transmission of COVID-19 could overwhelm health care services, compromising delivery of cancer care. This interim consensus guidance provides advice for clinicians managing patients with cancer during the pandemic. MAIN RECOMMENDATIONS: During the COVID-19 pandemic: In patients with cancer with fever and/or respiratory symptoms, consid...
Source: Med J Aust - Category: General Medicine Authors: Tags: Med J Aust Source Type: research
Immune checkpoint inhibitors (ICPIs) have revolutionized the management and prognosis of fit patients with advanced non-small cell lung cancer (NSCLC). Recently, the publication of 5-year survival rates has cemented to role of ICPIs in NSCLC. An ongoing challenge is to determine the optimal treatment duration to find the balance between efficacy, toxicity and cost. From the onset of ICPI trials, different durations were used, ranging from treatment until progression or toxicity, to fixed durations of 2 years. Subsequently, exploratory analyses from a 1-year fixed duration trial failed to change practice. There are, to date...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Source: Clinical Oncology - Category: Radiology Authors: Tags: Guidelines Source Type: research
Since December 2019, a novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initially reported un Wuhan, China, rapidly spread in other 114 countries worldwide, becoming pandemic.1
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
We would like to thank Troost et al. [1] and Magrini et al. [2] for their feedback and for opening a broader discussion about radiotherapy treatment of COVID-19 positive lung cancer patients during the time of the pandemic [3]. We propose differentiating two separate aspects and risk categories which need to be considered in this situation.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Source Type: research
More News: Cancer | Cancer & Oncology | COVID-19 | Hematology | Hospitals | Lung Cancer | Pandemics